EPISODE-III Trial Results – presented at the 2026 ASCO Annual Meeting At the 2026 ASCO, the EPISODE-III Trial team presented the results of the trial that was conducted at 36 institutions in Japan ...
News
If you wish to view this page in your preferred RSS reader, you can access the RSS feed here.
Patients & Public
Patient Experiences at University Hospitals Coventry & Warwickshire NHS Trust Starting recruitment in 2015 and now having welcomed more than 10,000 participants, the Add‑Aspirin trial does not of ...
International collaboration sheds light on how aspirin prevents cancer
A research collaboration led from the MRC CTU at UCL suggests that the anti-cancer effects of aspirin are mediated through suppression of platelet activation.
ALASSCA trial in PIK3CA-mutated Colorectal Cancer
ALASSCA Trial Results – 2025 ASCO Gastrointestinal Cancer Symposium. The ALASCCA trial, recently presented at ASC0 2025, evaluated aspirin after colorectal cancer resection in patients whose tumou ...
News and Resources